pMuLE (L1-L4) 4X PRE
(Plasmid
#206167)
-
PurposepMuLE L1-L4 entry plasmid containing 4 consensus PGR bindings sites upstream of a minimal 2YBTATA promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 206167 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepMuLE ENTR MCS L1-L4
- Backbone size w/o insert (bp) 2668
- Total vector size (bp) 2755
-
Vector typeGateway cloning entry clone
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert name4X PRE
-
SpeciesH. sapiens (human), Synthetic; PRE is human PGR binding site, 2YBTATA is a synthetic minimal promotor
-
Insert Size (bp)138
- Promoter 2YBTATA
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (destroyed during cloning)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer M13 Fw
- 3′ sequencing primer M13 Rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made by4X PRE sites are the same as in Addgene plasmid #206159
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMuLE (L1-L4) 4X PRE was a gift from Renee van Amerongen (Addgene plasmid # 206167 ; http://n2t.net/addgene:206167 ; RRID:Addgene_206167) -
For your References section:
A molecular toolbox to study progesterone receptor signaling. Aarts MT, Wagner M, van der Wal T, van Boxtel AL, van Amerongen R. J Mammary Gland Biol Neoplasia. 2023 Nov 29;28(1):24. doi: 10.1007/s10911-023-09550-0. 10.1007/s10911-023-09550-0 PubMed 38019315